Chudnovsky Yekaterina
SEC insider (Form 3/4/5 filer). CIK 0001979324. Director & 10% Owner at Elicio Therapeutics, Inc. (ELTX) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in BOSTON, MA.
Companies Chudnovsky Yekaterina has filed insider reports for
- Elicio Therapeutics, Inc. (ELTX): Director, 10% Owner
- Immix Biopharma, Inc. (IMMX): Director
- Xilio Therapeutics, Inc. (XLO): 10% Owner
Chudnovsky Yekaterina
CIK: 0001979324
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 31, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.8K shares- - May 22, 2026IMMX
Immix Biopharma, Inc.
AwardDirect6.3K shares- - Jun 20, 2025IMMX
Immix Biopharma, Inc.
AwardDirectStock Option (Right to Buy)
33K shares- - Jun 3, 2025ELTX
Elicio Therapeutics, Inc.
AwardIndirectWarrant (right to buy)
103.2K shares- - May 19, 2025ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
7.9K shares- - Mar 5, 2025ELTX
Elicio Therapeutics, Inc.
ConversionIndirect3.5M shares at avg. $5.81$20.3M - Nov 21, 2024ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
4.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,750 | - | - | Direct |
| May 22, 2026 |  IMMX Immix Biopharma, Inc. | Award | 6,250 | - | $0 | Direct |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | Award Stock Option (Right to Buy) | 33,000 | - | - | Direct |
| Jun 3, 2025 | ELTX Elicio Therapeutics, Inc. | Award Warrant (right to buy) | 103,225 | - | - | Indirect |
| May 19, 2025 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 7,900 | - | - | Direct |
| Mar 5, 2025 | ELTX Elicio Therapeutics, Inc. | Conversion | 3,500,573 | $5.81 | $20,338,329 | Indirect |
| Nov 21, 2024 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 4,100 | - | - | Direct |
1-7 of 7 transactions